drugset / Trial / NCT01666769

Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation

NCT01666769

Phase 1 Completed 18 enrolled Kevin Watt
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Determine proper dosing of micafungin in children supported with extracorporeal membrane oxygenation (ECMO).

Timeline

Start
2013-01
Primary completion
2016-02-02
Completion
2016-02-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Micafungin Peptide 4 mg/kg Intravenous
Subject Micafungin Peptide 8 mg/kg Intravenous

Indications